{"schema_version":"secwatch.filing_event.v1","accession":"0001522767-24-000063","form_type":"8-K","ticker":"MRMD","cik":"0001522767","company_name":"MARIMED INC.","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.365513+00:00","generated_at":"2026-05-31T11:43:25.062948+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"MariMed Q2 2024 revenue $40.4M, GAAP net loss $1.6M, adjusted EBITDA $4.4M","bullets":["Revenue $40.4M, up 10.7% YoY from $36.5M; gross margin 42% (GAAP), 43% (non-GAAP).","GAAP net loss $1.6M vs loss $0.9M in Q2 2023; non-GAAP net loss $0.2M vs income $0.6M.","Non-GAAP adjusted EBITDA $4.4M (11% margin), down from $6.3M (17% margin) a year ago.","Retail transactions increased 24% YoY; wholesale segment led overall growth.","Management reaffirms 2024 financial targets; expects margin expansion and improved cash flow."],"urls":{"canonical":"https://secwatch.observer/filing/0001522767-24-000063","json":"https://secwatch.observer/filing/0001522767-24-000063.json","markdown":"https://secwatch.observer/filing/0001522767-24-000063.md","text":"https://secwatch.observer/filing/0001522767-24-000063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1522767/000152276724000063/0001522767-24-000063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1522767/000152276724000063/mrmd-20240807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:43:25.062948+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}